Rezolute
Redwood City, California, United States · Biotechnology, Biotechnology Research, Health Care
Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI).
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Redwood City, California, United States
- Employees
- 64
- Industries
- Biotechnology, Biotechnology Research, Health Care
- Status
- Public (RZLT)
- Website
- rezolutebio.com
- Company page
Recent activity at Rezolute
- : SEC 8-K (1.01): On November 13, 2026, Rezolute, Inc. entered into a Material Definitive Agreement through an Underwriting Agreement with Morgan Stanley & Co. LLC, Guggenheim Securities, LLC, and Cantor Fitzgerald & Co. The agreement pertains to the issuance and sale of 22,040,976 shares of common stock at an offering price of $3.8700 per share and pre-funded warrants to purchase up to 3,800,000 shares at $3.8690 per warrant. The estimated net proceeds from the offering are approximately $93.5 million, intended for commercialization preparation and working capital. The closing is expected on or about November 16, 2026, subject to customary conditions, and includes lock-up provisions for the Company's executive officers and directors for 30 days post-offering.
- : SEC 8-K (8.01):
- : SEC 8-K (7.01): Rezolute, Inc. provided a Regulation FD Disclosure concerning its newly prepared Investor Presentation released on October 29, 2026. The presentation materials are intended for use in communications with current and potential investors, analysts, lenders, and other stakeholders interested in the Company. It highlights forward-looking statements and uncertainties pertaining to the Company's future plans and strategies. This report does not constitute a filing under the Securities Exchange Act and includes cautionary statements regarding reliance on the statements made.
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
About Rezolute: questions and answers
What does Rezolute do?
Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI).
Where is Rezolute headquartered?
Rezolute is headquartered in Redwood City, California, United States.
How many employees does Rezolute have?
Rezolute has about 64 employees.
What is the latest news on Rezolute?
On Oct 29, 2026, SEC 8-K (1.01): On November 13, 2026, Rezolute, Inc. entered into a Material Definitive Agreement through an Underwriting Agreement with Morgan Stanley & Co. LLC, Guggenheim Securities, LLC, and Cantor Fitzgerald & Co. The agreement pertains to the issuance and sale of 22,040,976 shares of common st
Is Rezolute a public company?
Yes. Rezolute is publicly traded under the ticker RZLT.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy